Physician profile
Samir Ouais
NPI 1861559213
$8,523.62
in general payments reported to CMS, 2019-2025
55 companies · $1,661 in 2025
The $1,661 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,852 · 2020: $278 · 2021: $388 · 2022: $1,436 · 2023: $1,539 · 2024: $1,370 · 2025: $1,661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,570.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $999.84 | 2019-2025 | Jardiance, Mounjaro, Lyumjev |
| Bayer Healthcare Pharmaceuticals INC. | $696.44 | 2021-2025 | |
| Dexcom, INC. | $578.59 | 2022-2024 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Amgen INC. | $531.81 | 2019-2025 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals LP | $474.69 | 2019-2024 | Lokelma |
| Novo Nordisk INC | $449.89 | 2019-2025 | Sogroya, Ozempic, Rybelsus |
| Madrigal Pharmaceuticals | $396.78 | 2024-2025 | Rezdiffra |
| Mannkind Corporation | $352.72 | 2019-2023 | Afrezza |
| Ascensia Diabetes Care US INC. | $350.99 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $323.20 | 2019-2023 | |
| Beta Bionics, INC. | $300.94 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Intuity Medical INC | $281.34 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Corcept Therapeutics | $237.62 | 2021-2025 | Korlym |
| Cequr Corporation | $204.36 | 2023-2024 | Cequr Simplicity |
| Xeris Pharmaceuticals, INC. | $193.86 | 2022-2025 | Gvoke Hypopen |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valeritas, INC. | $186.95 | 2019 | |
| Sequel Med Tech, LLC | $150.84 | 2025 | Twiist |
| Ultragenyx Pharmaceutical INC. | $123.38 | 2021 | |
| Insulet Corporation | $121.55 | 2019-2025 | Omnipod |
| Abbvie INC. | $104.98 | 2021-2025 | |
| Gilead Sciences, INC. | $103.09 | 2019 | |
| Shire North American Group INC | $90.84 | 2019 | |
| Radius Health, INC. | $90.68 | 2022-2024 | Tymlos |
| Medtronic, INC. | $87.16 | 2023-2025 | Intellis Adaptivestim, Minimed 780g, Inpen Smart Insulin Delivery System |
| Medtronic Minimed, INC. | $83.63 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.68 | 2019-2024 | Cycloset |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.39 | 2019-2024 | Jardiance, Synjardy |
| Averitas Pharma INC. | $57.71 | 2024-2025 | Qutenza |
| Amneal Pharmaceuticals LLC | $51.11 | 2022-2025 | Unithroid |
| Abbott Laboratories | $49.00 | 2023-2024 | Freestyle Libre 3, Proclaim |
| Nevro Corp. | $47.73 | 2022-2024 | Senza |
| Recordati_rare_diseases_inc. | $47.51 | 2021-2022 | |
| Eisai INC. | $47.36 | 2019 | |
| Ibsa Pharma INC. | $47.00 | 2020-2023 | Tirosint, Licart |
| Avvisto Therapeutics, LLC | $46.69 | 2025 | Cycloset |
| Curium US LLC | $45.58 | 2022-2024 | Detectnet |
| Kyowa Kirin, INC. | $39.60 | 2024-2025 | Crysvita |
| Zealand Pharma US, INC. | $37.36 | 2020-2021 | |
| Exact Sciences Corporation | $33.11 | 2023-2024 | Cologuard Collection Kit |
| Melinta Therapeutics, LLC | $28.45 | 2019 | |
| Horizon Therapeutics Plc | $27.38 | 2020 | |
| Tandem Diabetes Care, INC. | $26.62 | 2022 | |
| Ascendis Pharma Endocrinology INC | $26.04 | 2025 | Yorvipath |
| Merck Sharp & Dohme LLC | $24.99 | 2019-2020 | |
| Eusa Pharma (US) LLC | $23.47 | 2022 | |
| Pfizer INC. | $20.98 | 2019 | |
| Inspire Medical Systems, INC. | $20.67 | 2024 | Inspire |
| Azurity Pharmaceuticals, INC. | $19.76 | 2025 | Azmiro |
| Companion Medical, INC. | $18.24 | 2019 | |
| Currax Pharmaceuticals LLC | $17.28 | 2024 | Contrave |
| Esperion Therapeutics, INC. | $16.31 | 2025 | Nexletol |
| Amryt Pharma Holdings LTD | $16.21 | 2023 | Mycapssa |
| Paratek Pharmaceuticals, INC. | $14.39 | 2021 | |
| Amarin Pharma, INC. | $13.99 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Ouais listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.